Plasmodium falciparum HSP90 inhibitors show divergent resistance despite a shared ATP-binding site
Cell Reports · 2026-07 · 45 (7) · 117664
DOI: 10.1016/j.celrep.2026.117664 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2026-07. Verfasst von Fu-Hsuan Ko und 23 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biological Sciences, University of California, La Jolla, San Diego, CA, USA; Department of Pediatrics, University of California, San Dieg…. Hauptthemen laut MEDLINE: HSP90 Heat-Shock Proteins, Plasmodium falciparum, Drug Resistance, Adenosine Triphosphate. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bill & Melinda Gates Foundation, NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Drug resistance poses a major challenge across therapeutic areas including malaria, yet factors governing resistance propensity remain poorly understood. We demonstrate that two HSP90 inhibitors targeting the identical ATP-binding site exhibit dramatically different resistance profiles in P. falciparum. Geldanamycin readily selected 10 distinct resistance mutations conferring up to 22-fold resistance, while AUY-922 required 44 weeks to yield a single A41S mutation with only 2-fold resistance. Resistance mutations mapped throughout geldanamycin's binding pocket but localized near the ATP-binding site for AUY-922. Strikingly, A41S enhanced AUY-922 binding affinity via additional hydrogen bonding, yet stronger binding paradoxically correlated with resistance. Conditional HSP90 knockdown increased geldanamycin sensitivity but not AUY-922 activity, indicating distinct target dependencies despite shared binding sites. We propose AUY-922's lower resistance risk reflects engagement of multiple HSP90 family members. These findings demonstrate that resistance risk cannot be predicted from binding site identity alone, informing development of more durable therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Biological Sciences, University of California, La Jolla, San Diego, CA, USA; Department of Pediatrics, University of California, San Diego, San Diego School of Medicine, La Jolla, San Diego, CA, USA.
- Infectious Disease and Microbiome Program, The Broad Institute, Cambridge, MA, USA; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
- Department of Pediatrics, University of California, San Diego, San Diego School of Medicine, La Jolla, San Diego, CA, USA.
- Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA; Center for Malaria Therapeutics and Antimicrobial Resistance, Division of Infectious Diseases, Department of Medic…
- Biological Chemistry and Drug Discovery, Wellcome Centre for Anti-Infectives Research, University of Dundee, Dundee, UK.
- Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK.
Förderung
- Bill & Melinda Gates Foundation
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- Gates Foundation
Zitieren
APA
Ko, F. H., Lukens, A. K., Laureano de Souza, M., Foy, A., Hsiao, J., Ndiaye, T., Okombo, J., Yeo, T., Park, H., Uhlemann, A. C., Boonyalai, N., Kumpornsin, K., Girling, G., Pasaje, C., Godoy, L., Kapoor, P., Durst, G. L., Ottilie, S., Chatterjee, A., …, & Winzeler, E. A. (2026). Plasmodium falciparum HSP90 inhibitors show divergent resistance despite a shared ATP-binding site. Cell Reports, 45(7), 117664. https://doi.org/10.1016/j.celrep.2026.117664
Vancouver
Ko FH, Lukens AK, Laureano de Souza M, Foy A, Hsiao J, Ndiaye T, et al. Plasmodium falciparum HSP90 inhibitors show divergent resistance despite a shared ATP-binding site. Cell Reports. 2026;45(7):117664. doi:10.1016/j.celrep.2026.117664
BibTeX
@article{Ko2026,
author = {Ko, Fu-Hsuan and Lukens, Amanda K and Laureano de Souza, Mariana and Foy, Alex and Hsiao, Jason and Ndiaye, Tolla and Okombo, John and Yeo, Tomas and Park, Heekuk and Uhlemann, Anne-Catrin and Boonyalai, Nonlawat and Kumpornsin, Krittikorn and Girling, Gareth and Pasaje, Charisse and Godoy, Luiz and Kapoor, Priyan and Durst, Gregory L and Ottilie, Sabine and Chatterjee, Arnab and Niles, Jacquin and Lee, Marcus and Fidock, David A and Wirth, Dyann F and Winzeler, Elizabeth A},
title = {Plasmodium falciparum HSP90 inhibitors show divergent resistance despite a shared ATP-binding site},
journal = {Cell Reports},
year = {2026},
volume = {45},
number = {7},
pages = {117664},
doi = {10.1016/j.celrep.2026.117664}
}
EUVIMED